37 results on '"Erol Göka"'
Search Results
2. Evaluation of dsyfunctional attitudes, distress and discomfort tolerance levels in patients with premenstruel dysphoric disorder (tur)
- Author
-
Gamze Erzin, Oğuzhan Kılınçel, Şenol Bayram, Osman Hasan Tahsin Kılıç, Vahap Ozan Kotan, Güven Özkaya, Erol Göka, and Kadir Özdel
- Subjects
premenstrual dysphoric disorder ,discomfort tolerance ,distress tolerance ,dsyfunctional attitudes ,Psychiatry ,RC435-571 ,Therapeutics. Psychotherapy ,RC475-489 - Abstract
INTRODUCTION[|]Distress tolerance and Discomfort tolerance are well-established psychological constructs that are related but distinct. Distress tolerance is defined as an individual's perceived capacity to withstand negative emotional states or the capacity to continue goal-directed behavior in the context of negative affect. As for discomfort tolerance, it mainly is about the capacity to withstand negative bodily sensations. Premenstrual dysphoric disorder (PMDD) which consists of bodily and psychological symptoms is a DSM-5 diagnosed disease determined under the category of depressive disorders.In this research article, we investigated the possible effects of premenstrual dysphoric disorder on distress and discomfort tolerance levels as well as dysfunctional attitudes on individuals with this disorder. [¤]METHODS[|]In our study, 218 people were interviewed in total. People who could possibly have PMDD according to Premenstrual Symptoms Screening Tool (PSST) were monitored for 8 weeks and 31 people were diagnosed with PMDD. People without PMDD and having under threshold symptoms for PMDD according to PSST who have matching age and BMI were also included in the study. Distress Tolerance Scale (DTS), Discomfort Intolerance Scale (DIS), Dysfunctional Attitude Scale-short forms (DAS-sf) were filled for each sample. [¤]RESULTS[|]DTS self-efficacy scores were found to be higher in group without PMDD than the groups with PMDD and having under threshold symptoms. DAS-total score was found to be higher in group with PMDD than the groups without PMDD group and having under threshold symptoms group. Discomfort avoidance subscale score of distress tolerance scale was found to be higher compared to participants without PMDD and participants having below threshold symptoms. [¤]DISCUSSION AND CONCLUSION[|]Women with PMDD may benefit from preventive treatment modalities that minimize discomfort and avoidance behaviours and facilitate their coping with negative bodily sensations of premenstrual syndrome and prevent the development of dysfunctional attitudes toward these bodily and mental disturbing sensations. [¤]
- Published
- 2020
- Full Text
- View/download PDF
3. Erkek alkol bağımlılığı hastalarında tedavi motivasyonu, bağımlılık özellikleri, aşerme ve mizaç özellikleri ilişkisi
- Author
-
Gamze ERZİN, Oğuzhan KILINÇEL, Ahmet KOKURCAN, Merve CİNGİ YİRUN, İhsan Tuncer OKAY, İlker DALĞAR, and Erol GÖKA
- Subjects
alkol ,aşerme ,motivasyon ,alcohol ,craving ,motivation ,temperament traits ,Medicine (General) ,R5-920 - Abstract
Amaç: Bu araştırmanın amacı, yatarak tedavi gören erkek alkol bağımlılarında tedavi motivasyonu, bağımlılık özellikleri, aşerme ve mizaç özellikleri arasındaki ilişkiyi incelemektir.Gereç ve Yöntem: Ankara Numune Eğitim ve Araştırma Hastanesi, Alkol-Madde Araştırma, Tedavi ve Eğitim Merkezi’nde (AMATEM) yatarak tedavi gören DSM-IV-TR’ye göre alkol bağımlılığı tanısı almış erkek hastalar çalışmaya dahil edilmiştir. Hastalar, sosyodemografik veri formunun yanı sıra, Penn Alkol Aşerme Ölçeği (PAAÖ), Bağımlılık Profil İndeksi (BAPİ), Değişime Hazır Olma ve Tedavi İsteği Ölçeği (SOCRATES), Memphis, Pisa, Paris ve San Diego - Self Mizaç Değerlendirme Ölçeği (TEMPS-A) kullanılarak değerlendirildi.Bulgular: Çalışmaya 85 erkek hasta dahil edildi. Çalışma kapsamındaki hastaların ortalama yaşı 46.36 ± 9.66’ydı. Katılımcıların ortalama alkol kullanma süreleri ise 23.32 ± 10.33 yıldı. Çalışmanın sonuçlarına göre BAPİ toplam puanı ve PAÖÖ toplam puanı arasında pozitif korelasyon hesaplanmıştır.Sonuç: Bağımlılık şiddetinin artmasıyla aşerme şiddetinin artması bağımlılık şiddeti yüksek olan hastalarda aşerme konusunda daha dikkatli olmak gerektiğini düşündürebilir. Baskın mizaç özelliğine sahip olup olmamanın aşerme, motivasyon ve bağımlılık şiddeti ile olan ilişkisi çalışmamızda saptanmamıştır.
- Published
- 2020
- Full Text
- View/download PDF
4. A case of generalized edema associated with risperidone monotherapy
- Author
-
Omer Asan, Elif Tatlidil Yaylaci, and Erol Göka
- Subjects
adverse effect ,edema ,risperidone ,schizophrenia ,Psychiatry ,RC435-571 ,Therapeutics. Psychotherapy ,RC475-489 - Abstract
Risperidone is a second-generation antipsychotic agent, widely used in psychiatric disorders like schizophrenia, bipolar disorder, and aggression. Edema has been reported as a side effect of risperidone in a few case reports in the literature. In most of these cases, another drug was combined with risperidone and edema was located in a specific zone. Here we aimed to report a case of generalized edema due to risperidone oral monotherapy and reviewed the relevant literature.
- Published
- 2019
- Full Text
- View/download PDF
5. Pregabalin abuse among patients with opioid use disorders may increase the severity of withdrawal symptoms: a single-center, case-control study
- Author
-
Özlem Çıtak Ekici, Volkan Şahiner, Gamze Erzin, Davut Ocak, Şafak Yalçın Şahiner, and Erol Göka
- Subjects
opioid ,pregabalin ,withdrawal ,addiction ,craving ,motivation ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
OBJECTIVE: Opioid addiction is a disease that is increasing in our country, Turkey, and around the world, which it is difficult to treat in medical, social, and economic terms. Pregabalin is a preparation used for the treatment of epilepsy, neuropathic pain, and anxiety disorders. In opioid users, pregabalin is increasingly being self-administered off-label due to its euphoria effect at high doses. We investigated the effects of pregabalin on addiction profile and opioid withdrawal severity by comparing patients with opioid addiction who were and were not using off-label pregabalin. METHODS: Between July and August 2016, a total of 120 patients (60 patients were pregabalin users and 60 patients were non-users) who presented to Ankara Numune Training and Research Hospital Psychiatry Clinic Alcohol and Substance Addiction Treatment Center and were diagnosed with opioid use disorder according to the DSM-5, were included in the study. Patients who were using other substances were excluded from the study. A sociodemographic data form, the Clinical Opiate Withdrawal Scale, and Addiction Profile Index (API) were applied to the patients. RESULTS: There was no statistically significant difference between pregabalin users and pregabalin non-users in terms of age, sex, age of onset, working status, and whether previous treatment had been received. In the pregabalin user group, the severity of opioid withdrawal, API substance use characteristics, diagnosis, effects on life, craving, motivation subscale scores, and API total score were found to be significantly higher than in the non-user group. CONCLUSION: Off-label pregabalin use among patients with opioid addiction is becoming more common. Off-label, high-dose pregabalin use may worsen existing opioid addiction, create a new area of addiction, and an illegal market. Highlights We aimed to investigate the effects of pregabalin on addiction profile and opioid withdrawal severity by comparing patients with opioid addiction who were and were not using off-label pregabalin. In the pregabalin user group, the severity of opioid withdrawal, and API total score were found to be significantly higher than in the non-user group. The use of off-label, high-dose pregabalin may worsen existing opioid addiction.
- Published
- 2019
- Full Text
- View/download PDF
6. The severity of dissociative symptoms among patients with cannabis and synthetic cannabinoid use disorder: association with substance use characteristics and suicide
- Author
-
Bengü Yücens, Vahap Ozan Kotan, İhsan Tuncer Okay, and Erol Göka
- Subjects
substance addiction ,cannabis ,dissociation ,suicide ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
OBJECTIVE: Cannabis (C) and synthetic cannabinoids (SCs) are commonly used substances. Pharmacodynamic and pharmacokinetic differences predict that SCs involve a greater risk of dependence than C. Dissociative symptoms and suicidality are also frequent in treatment-seeking substance users, however, there is not enough data about the dissociative effects of C and SCs. The present study aimed to examine SC users in terms of demographic features and severity of dissociative symptoms in comparison to C users. It was also aimed to explore the relationships between dissociation and suicide attempts. METHODS: The study was performed at the Alcohol and Substance Research, Treatment, and Training Centre of Ankara Numune Training and Research Hospital, Turkey. 84 patients with C or SC use disorder included in the study and all the participants were administered a sociodemographic data form assessing also substance use features and suicide attempts and Dissociative Experiences Scale (DES). The patients were separated into three groups as only C users (CU), only SC users (SCU) and both C and SC users (C&SCU) and also categorized as DES score
- Published
- 2019
- Full Text
- View/download PDF
7. Secretagogin may not be a new neuroendocrine biomarker in schizophrenia while levels may reflect clinical severity
- Author
-
Gamze Erzin, Canan Topçuoğlu, Şenol Bayram, Hasan Karadağ, Güven Ozkaya, Turan Turhan, and Erol Göka
- Subjects
schizophrenia ,neuroendocrine ,peripheral markers ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
OBJECTIVE: Schizophrenia is a neurodegenerative and neurodevelopmental disorder. For this reason, it is important to determine the level of markers that are neuroprotective and have been altered in other neurodegenerative diseases in inspecting the etiology of schizophrenia. Secretagogin (SCGN), is a member of Calcium (Ca) binding proteins and thought to have a neuroprotective effect. In this study, we aimed to compare the level of secretagogin (SCGN) between age and gender-matched schizophrenia and control group. METHODS: Fifty-three patients with schizophrenia who applied to outpatient clinics of our hospital and 37 healthy controls included in the study. Schizophrenia diagnoses of the patients were verified using the DSM-5 criteria. Serum secretagogin levels were measured with the enzyme-linked immunosorbent assay (ELISA) test. The Body Mass Index (BMI) of the patient group was measured. RESULTS: There was no significant difference between the controls and patients in terms of fasting blood glucose and insulin levels. We did not find any difference in terms of the levels of serum secretagogin between patients with schizophrenia and controls. Negative correlations were found between the level of secretagogin and PANSS positive score, PANSS negative score, PANSS general psychopathology score. CONCLUSION: There is increasing evidence that SCGN may play a role in central nervous system (CNS) activity. Future studies might help to explicitly present the relationship between secretagogin and schizophrenia.
- Published
- 2019
- Full Text
- View/download PDF
8. Examination of formal thought disorder and its clinical correlates with the Turkish Version of the Thought and Language Disorder Scale (TALD-TR) in schizophrenia
- Author
-
Emre Mutlu, M. Kâzım Yazıcı, Elif Barışkın, Aygün Ertuğrul, Ş. Can Gürel, Şahin Gürkan, Erol Göka, and A. Elif Anıl Yağcıoğlu
- Subjects
Psychiatry ,RC435-571 - Abstract
Background: Formal thought disorder (FTD) is considered to be a fundamental feature of schizophrenia. This study aims to analyze psychometric properties of the Turkish version of “Thought and Language Disorder Scale (TALD)” and investigate the relationship between FTD and various clinical characteristics in patients with schizophrenia. Methods: TALD was adapted into Turkish and applied to a total of 149 participants of which 114 had DSM-5 psychiatric diagnoses (schizophrenia N = 70, mania N = 20, depression N = 24) and 35 were healthy controls. Positive and Negative Syndrome Scale (PANSS), Hamilton Depression Rating Scale, Young Mania Rating Scale, and Clinical Global Impression were administered to detect illness severity. Results: The principal component analyses revealed that the Turkish version of TALD (TALD-TR) consisted of four factors including the Objective Positive (OP), Subjective Negative (SN), Objective Negative (ON) and Subjective Positive (SP) symptom dimensions which were in line with the original TALD factorial structure. It was concluded that TALD-TR shows strong construct validity and high interrater reliability. The correlation analyses with TALD-TR and PANSS showed that there are positive correlations between the TALD-TR total score and the PANSS total and subscale scores. Each diagnostic group showed the distinct pattern of FTD. The mania group exhibited the highest mean total score in the OP, whereas the schizophrenia group exhibited the highest mean total score in the ON factor. In the schizophrenia group, the severity of FTD correlated positively with duration of illness and negatively with age at onset of illness. Conclusion: Adaptation of TALD into different languages seems to be possible, bringing in an international tool for research on FTD. Keywords: Formal thought disorder, Schizophrenia, Mania, Depression, Language processing
- Published
- 2019
- Full Text
- View/download PDF
9. Serum 15-d-PGJ2 and PPARγ levels are reduced in manic episode of bipolar disorder while IL-4 levels are not affected
- Author
-
Gamze Erzin, Makbule Çiğdem Aydemir, Rabia Nazik Yüksel, Elif Tatlıdil Yaylacı, Bağdagül Çakır, Sevilay Sezer, and Erol Göka
- Subjects
bipolar disorder ,pparγ ,15d-pgj2 ,cytokine ,neuroinflammation ,peripheral markers ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
OBJECTIVES: Bipolar disorder (BD) carries a high rate of morbidity and mortality, and the clarification of its aetiology continues to be an important field of research. In recent studies, the clinical characteristics of BDs have been explained through a number of underlying factors, including cytokines, steroids, neurotrophins, mitochondrial energy generation, oxidative stress, and neurogenesis. In this study, we aimed to investigate potential associations between BDs and inflammatory processes. METHODS: Patients with mania or in remission who attended outpatient clinics of the Department of Psychiatry of the Ankara Numune Training and Research Hospital, and who were diagnosed with BD according to the DSM-V criteria, were included in the study. IBM SPSS Statistics 23 software was used for statistical analyses of the data. The normality of the distribution of continuous and discrete numerical variables was tested with a Shapiro–Wilk Test. RESULTS: In this study, the measurements and statistical analyses revealed significantly lower 15-deoxy delta12, 14-prostaglandin J2 (15d-PGJ2) and Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) levels in patients with mania in comparison to healthy controls and patients in remission. Group comparisons did not reveal any significant differences between IL-4 levels. CONCLUSIONS: This study was not a longitudinal study evaluating the same patients during both relapse and remission periods; no group of patients in a depressive episode of BD were included in the group comparisons either. Although this evidence is not adequate for a definite conclusion, the available evidence suggests that anti-inflammatory markers such as 15d-PGJ2 and IL-4 and nuclear PPARγ receptors are potential biomarkers to clarify the aetiology of BD, and these markers may be included among the therapeutic targets for future pharmacological modulations. Further studies are required in this area.
- Published
- 2019
- Full Text
- View/download PDF
10. The relationship between internalized stigma and treatment motivation, perceived social support, depression and anxiety levels in opioid use disorder
- Author
-
Emine Merve Akdağ, Vahap Ozan Kotan, Samet Kose, Baise Tıkır, Makbule Çiğdem Aydemir, İhsan Tuncer Okay, Erol Göka, and Güven Özkaya
- Subjects
Substance use disorder ,internalized stigma ,treatment motivation ,social support ,depression ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
OBJECTIVE: This study aims to examine how internalized stigma differs in opioid use disorder (OUD) based on sociodemographic and clinical variables, and to what extent internalized stigma is related to treatment motivation, perceived social support, depression, and anxiety levels. METHODS: One hundred forty-five individuals with OUD included. Sociodemographic and clinical data form, the Internalized Stigma of Mental Illness Scale (ISMI), Treatment Motivation Questionnaire (TMQ), Multidimensional Scale of Perceived Social Support, the Beck Depression Inventory, and the Beck Anxiety Inventory were utilized in the study to collect data. Bivariate and partial correlation coefficients between variables were computed. ISMI and TMQ scores were compared between patients with depressive symptoms and patients without depressive symptoms by using t-test and Mann Whitney U test. RESULTS: Internalized stigma was high among male patients with heroin use disorder. There was a positive correlation between internalized stigma score and treatment motivation, depression, and anxiety levels. On the other hand, there was a negative correlation between internalized stigma score and multidimensional perceived social support. CONCLUSION: Internalized stigma occupies an important place in the treatment of OUD, which occurs with frequent relapses and which is hard to treat. Not only application for treatment but also adherence to treatment and treatment motivation at maintenance phase bestow a complicated relationship with depression and anxiety. In the struggle against internalized stigma, it plays a vital role to mobilize people’s social support systems, to educate families on the issue and to get in touch with support units exclusive to heroin users.
- Published
- 2018
- Full Text
- View/download PDF
11. Oral Research Presentations
- Author
-
Hatice Gözde Akkın Gürbüz, Levent Turhan, Nilgun Şendil, Halim Ömer Kaşıkçı, Banu Salepçi, Derya Ipekcioglu, Canan Kuygun Karcı, Perihan Çam Ray, Ayşegül Yolga Tahiroğlu, Ayşe Avcı, Gonca Gül Çelik, Necmi Cekin, Nurdan Evliyaoğlu, Mehmet Alkanat, Hafize Özdemir, Egemen Akgün, Mehmet Emin Demirkol, Lut Tamam, Erman Esnafoglu, Doğa Sevinçok, Çağdaş Öykü Memiş, Bilge Doğan, Burcu Çakaloz, Ayşe Kutlu, Levent Sevinçok, Sema Nur Türkoğlu Dikmen, Yasir Şafak, Rıza Gökçer Tulacı, İlker Özdemir, Sema Baykara, Kübra Alban, Nazan Aydın, Hasan Mervan Aytaç, Doğan Yılmaz, Pınar Çetinay Aydın, Gökşen Yüksel Yalçın, Cana Canbay, Merve Terzioğlu, Aysel Özer, Ebru Altintas, Meryem Özlem Kütük, Ali Evren Tufan, Harika Gözükara Bağ, Güliz Şenormancı, Oya Güçlü, Cemil Çelik, Abdullah Bolu, Taner Öznur, Mehmet Sinan Aydın, Yusuf Tokgöz, Özcan Uzun, Sakır Gıca, Burç Çağrı Poyraz, Yağmur Sever Fidan, Hüseyin Güleç, Erdoğdu Akça, Mesut Yıldız, Zeynep Nur Demirok Akça, Yusuf Öztürk, Gonca Özyurt, Kadir Özdel, Gulcin Elboga, Muhammet Berkay Ozyurek, Abdullah Akgün, Ali Coşkun, Ayhan Bilgiç, Rukiye Çolak Sivri, İbrahim Kılınç, Ahmet İnal, Uğur Eray, Murat Acat, Arif Önder, Aslı Sürer Adanır, Canem Kavurma, Öznur Bilaç, Yakup Doğan, Rukiye Ay, Çağatay Uğur, Betül Gül Alıç, Mehmet Gündüz, Özlem Ünal, Ömer Uçur, Özlem Özcan, Hasret Karabulut Gül, Demet Sağlam Aykut, Ahmet Tiryaki, Filiz Civil Arslan, Gül Alkan Bülbül, Ömer Yolcu, Aysel Uysal, Esin Özatalay, Selma Cırrık, Esin Erdogan, Dursun Hakan Delibas, Hazan Tomar Bozkurt, Rukiye Tekdemir, Vefa Erbasan, Okan İmre, Memduha Aydın, Kürşat Altınbaş, Başak Karabucak, Halime Tuna Çak Esen, Sadriye Ebru Çengel Kültür, Remzi Karaokur, Songül Atasavun Uysal, Nurhan Erbil, Meltem Çiğdem Kirazlı, Tayfun Kara, Ajda Mutlu Mıhçıoğlu, Semra Yılmaz, İsmail Akaltun, Abdullah Atli, Zübeyir Can, Emine Füsun Akyüz Çim, Aslıhan Okan İbiloğlu, Nilfer Şahin, Hülya Ertekin, Zehra Başar Kocagöz, Adnan Özçetin, Ahmet Ataoğlu, Şengül Cangür, Safiye Bahar Ölmez, Neslihan Yazar, Halit Necmi Uçar, Duygu Murat, Şafak Eray, Yaşar Tanır, Hatice Altun, Mehmet Hanifi Tanyeri, Mehmet Emin Büyükokuroğlu, Pelin Tanyeri, Oguz Mutlu, Füruzan Yıldız Akar, Güner Ulak, Bekir Faruk Erden, Feyza Hatice Sevgen, Asiye Arıcı, Fethiye Kılıçaslan, Mehmet Fatih Erbay, Cengiz Darılmaz, Fikret Poyraz Çökmüş, Serra Yüzeren, Didem Sücüllüoğlu Dikici, Orkun Aydın, Pınar Ünal Aydın, Fatma Akdeniz, Siğnem Öztekin, Emine Özge Çöldür, Kuzeymen Balıkçı, Ertuğrul Köroğlu, Ömer Aydemir, Hüseyin Kara, Özgen Özçelik, Mehmet Murat Balcı, Mehmet Murat Kuloğlu, Talya Tomar, Fatma Taneli, Arzu Oran, Gülgün Yılmaz Ovalı, Gamze Yapça Kaypaklı, Özge Metin, Hakan Karaş, Halil Çetingök, Reşat İlişer, Elif Çarpar, Muzaffer Kaşer, Güneş Şayan Can, Gözde Ulaş, Ayşegül Ildız, Neslihan Emiroğlu, Emel Ada, Ayşegül Özerdem, Okan Imre, Oğuz Mutlu, Furuzan Yıldız Akar, Uğur Tekin, Ayşegül Satar, Ayşe Nur Aydın, Hatice Serpil Erermiş, Orhan Kocaman, Nihal Yurteri Çetin, Aynur Akay, Yüksel Sümeyra Karagöz, Özlem Doğan, Serenay Ülkar, Birim Günay Kılıç, Hacer Akgül Ceyhun, Esat Fahri Aydın, Tuba Ülkevan, Nilifer Gürbüzer, Hasan Cem Aykutlu, Işık Görker, Emel Özen, Evrim Aktepe, Mustafa Asım Aydın, Dudu Dilek Yavuz, Umut Karaaslan, Abdullah Karataş, Zehra Sancak, Erhan Eser, Mehmet Murat Demet, Mehmet Emrah Karadere, Ece Yazla Asafov, Halil İbrahim Ölçüm, Ayhan Algül, İbrahim Gündoğmuş, Fatih Hilmi Cetin, Hasan Ali Guler, Serhat Turkoglu, Bahar Keleş Çolpan, Elif Bayram, Funda Seher Özalp Ateş, Serap Tıraş Teber, Nagihan Saday Duman, Emel Sarı Gökten, Elif Nurgül Sungur, Melike Ceyhan Balcı Şengül, Ayşen Çetin Kardeşler, Yaşar Enli, Neslihan Kurtul, Cihan Aslan, Bahadır Konuşkan, Burçin Şener, Banu Anlar, Fatih Ünal, Bülent Devrim Akçay, Güray Koç, Sinan Yetkin, Serkan Bayad, Müge Elbir, Özge Alp Topbaş, Tuğba Kocabaş, Adem Aydın, Pelin Avcu Çelik, Deniz Argüz Çıldır, Aylin Özbek, Aybuke Tuğçe Mustan, Ayşe Sevgi Karadağ, Aysun Kalenderoğlu, Mehmet Hamdi Örüm, Murat Eren Özen, Oğuzhan Bekir Eğilmez, Dilek Bingöl Aydın, Bahri Elmas, Serhat Nasıroğlu, Engin Aydın, Öner Özdemir, Özcan Erel, Ülker Fedai, Mehmet Asoğlu, Rümeysa Yeni Elbay, Hasan Turan Karatepe, Celal Ulaşoğlu, Hamza Ayaydın, Berkan Şahin, Koray Karabekiroğlu, Abdullah Bozkurt, Miraç Barış Usta, Muazzez Aydın, Cansu Çobanoğlu, Yalçın Kahya, Dilara İnan, Ali Ercan Altınöz, Ferdi Köşger, Altan Eşsizoğlu, Mehmet Arslan, Ali Metehan Çalışkan, Duygu Göktaş, İkbal İnanlı, Saliha Çalışır, İbrahim Eren, Zeynep Baran Tatar, Erhan Kurt, Gokhan Unal, Feyza Aricioglu, Mustafa Esad Tezcan, Tuğba Kalyoncu, Fazilet Ergüvendi, Çigdem Yektaş, Recep Eroz, Gokhan Yurdakul, Mahmut Cakır, Mehmet Yalcin Tasmektepligil, Saliha Baykal, Mirac Barıs Usta, Melih Nuri Karakurt, Koray Karabekiroglu, Yasemin Yulaf, Funda Gümştaş, Sebla Gökçe, Yankı Yazgan, Doğa Sevincok, Tugba Kalyoncu, Fazilet Arkat Ergüvendi, İbrahim Yağcı, Sema Avcı, Yüksel Kıvrak, Alişan Burak Yaşar, Ceyhun Sayman, Serap Erdoğan Taycan, Yılmaz Çetinkaya, Anıl Gündüz, Hülya Tireli, Kemal Utku Yazici, Ipek Percinel Yazici, Pınar Aksu Kılıçle, Süleyman Gül, Ipek Percınel Yazici, Ayçin Darıcı Sümer, Esra Çöp, Duygu Bilgili, Müge Şahin, Gülser Şenses Dinç, Özlem Hekim, Emine Dibek Mısırlıoğlu, Funda Kurt, Zeynep Göker, Özden Üneri, Eray Atalay, İrem Yıldırım, Ali İnaltekin, Bengü Yücens, Vahap Ozan Kotan, Nihal Özkayar, Fatih Dede, Rabia Nazik Yüksel, Şenol Bayram, Zeynep Kotan, Erol Göka, Gökçe Nur Say, Merve Kalyoncu, Özlem Beğinoğlu, Bahadir Bilgin Basgoz, Semra Ince, Umut Safer, and İlker Tasci
- Subjects
Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Published
- 2018
- Full Text
- View/download PDF
12. Symposium Oral Presentations
- Author
-
Veysi Çeri, Hasan Cem Aykutlu, Işık Görker, Ömer Faruk Akça, Mahmut Cem Tarakçıoğlu, Umut Mert Aksoy, Heysem Kaya, Merve Sertdemir, Ezgi İnce, Muhammed Tayyib Kadak, Gökşen Yüksel Yalçın, Cavid Guliyev, Ayhan Bilgiç, Elvan Çiftçi, Kinyas Tekin, Zehra Olcay Tuna, Burcu Oğuzdoğan, Nagihan Saday Duman, Bengi Semerci, Özden Şükran Üneri, Koray Karabekiroglu, Tuba Mutluer, Melike Nebioglu, Şaziye Senem Başgül, Mehmet İlkin Naharcı, Özgür Maden, Çiçek Hocaoğlu, Onur Durmaz, Haluk Usta, Şükriye Boşgelmez, Meltem Puşuroğlu, Hale Yapıcı Eser, Murat Kaçar, Mahmut Çakır, Hasan Turan Karatepe, Ümit Işık, Halil Kara, Çağdaş Hünkar Yeloğlu, Esra Yazıcı, Anıl Gündüz, Kader Semra Karataş, Figen Yavlal, Necati Uzun, Ahmet Bulent Yazici, Şahin Bodur, Esma Akpınar Aslan, Sedat Batmaz, Feyza Çelik, Sadettin Burak Açıkel, Zehra Topal, Neslihan Altunsoy, Özge Demircan Tulacı, Ömer Faruk Demirel, Serhat Çıtak, Halime Tuna Çak, Abdül Baki Artık, Adnan Özçetin, Ilker Özdemir, Fatma Gül Helvacı Çelik, Sadriye Ebru Çengel Kültür, Arif Çipil, Rukiye Ay, Ayşe Rodopman Arman, Kemal Utku Yazıcı, Arzu Erkan Yuce, İpek Perçinel Yazıcı, Emel Kurt, Anıl Şafak Kaçar, Nurhan Erbil, Cana Aksoy Poyraz, Gamze Ergil Altın, Berkan Şahin, Özge Kılıç, Şenol Turan, Memduha Aydın, Erkan Kuru, Abdullah Bozkurt, Hüseyin Güleç, Merve Yalçınay İnan, Ali Emre Şevik, Saliha Baykal, Yusuf Karaer, Omer Yanartaş, Hatice Aksu, Serhat Ergün, Aynur Görmez, Mesut Yıldız, Sevda Bag, Ferda Korkmaz Özkanoğlu, Mecit Caliskan, Alişan Burak Yaşar, Emre Konuk, Murat Altın, Serkut Bulut, Gresa Çarkaxhiu Bulut, Rıza Gökçer Tulacı, Neşe Yorguner Küpeli, Necati Enver, İlker Tasci, Ayşe Sakallı Kani, Bülent Bahçeci, Gülay Oğuz, Gülçin Şenyuva, Gülşen Teksin Ünal, Çiğdem Yektaş, Mehmet Hamdi Örüm, Erol Göka, Şakir Gıca, Özge Şahmelikoğlu, Gülser Şenses Dinç, Serpil Erşan, Erdal Erşan, Mehmet Fatih Ceylan, Selma Tural Hesapçıoğlu, Mustafa Solmaz, Yasin Hasan Balcioglu, Mesut Cetin, Musa Tosun, Nihal Yurteri, Sevinc Ulusoy, Mehmet Emrah Karadere, Yüksel Kivrak, and Vahdet Görmez
- Subjects
Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Published
- 2018
- Full Text
- View/download PDF
13. Serum glial cell line-derived neurotrophic factor levels and impulsivity in heroin addiction: a cross-sectional, case-control study of 129 heroin addicts
- Author
-
Vahap Ozan Kotan, Rabia Nazik Yüksel, Zeynep Kotan, İhsan Tuncer Okay, Canan Topçuoğlu, Güven Özkaya, Şenol Bayram, and Erol Göka
- Subjects
Heroin addiction ,glial cell line-derived neurotrophic factor ,GDNF ,impulsivity ,anxiety ,depression ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
OBJECTIVE Glial cell line-derived neurotrophic factor (GDNF), being a protective of dopaminergic neurons, is reported to modulate addictive behaviours and have a role as a negative regulator for biochemical and behavioural adaptations to drug abuse. We aimed to reveal impulsivity and serum GDNF levels in patients with heroin addiction and investigate their relationships in order to contribute to the understanding of behavioural aspects and biological mechanisms in heroin addiction via this study. METHODS This study was performed at the Department of Psychiatry of Ankara Numune Training and Research Hospital, Turkey. We recruited 129 heroin-dependent patients and 90 age, sex, and smoking-matched healthy controls with no major psychopathology. Barratt Impulsivity Scale-11, Hospital Anxiety and Depression Scale (HADS) and sociodemographic data form were applied to all participants. Laboratory analysis for serum GDNF levels was performed for each participant’s blood sample. RESULTS Total impulsivity scores and scores of Attentional Impulsivity, Motor Impulsivity, and Unplanned Impulsivity subscales were all higher in heroin addicts compared to the controls. Heroin addicts had also lower serum GDNF levels and lower GDNF levels were associated with high impulsivity and high HADS scores in heroin addicts. CONCLUSION Decrement in GDNF levels in heroin addiction seems as to be an important data which could be associated with impulsivity, anxiety, and depressive symptoms. GDNF could find a prominent place among the target molecules in the treatment of heroin addiction.
- Published
- 2018
- Full Text
- View/download PDF
14. 9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology
- Author
-
Mine Elagoz Yuksel, Mahmut Cem Tarakçıoğlu, Ali Güven Kılıçoğlu, Ümit Işık, Bulent Bahçeci, Rümeysa Yeni Elbay, Kader Semra Karataş, Şahin Bodur, Özge Şahmelikoğlu Onur, Alişan Burak Yasar, Merve Çıkılı Uytun, Lale Gönenir Erbay, Mustafa Yıldız, Özlem Özcan, Erol Göka, Rukiye Ay, Sevda Bağ, Ömer Yanartaş, Ömer Faruk Demirel, Musa Tosun, Ayse Sakallı Kani, Hatice Altun, Kemal Utku, Yazici, H. Tuna Çak, Ipek Percinel, Yazici, Birim Günay Kılıç, Necati Uzun, Halil Kara, Gamze Ergil Altın, Fatma Hülya Çakmak, Rabia Yılmaz, Miray Çetinkaya, Sencan Sertçelik, Özhan Yalçın, Esra Porgalı Zayman, Nilfer Şahin, Funda Gümüştaş, Ebru Çengel Kültür, Serhat Ergün, Serhat Nasıroğlu, Sadettin Burak Açıkel, Özden Şükran Üneri, Hesna Gül, Murat Altın, Ferda Korkmaz Özkanoğlu, Zeynep Esenkaya Usta, Gözde Narin Coşkun, Aynur Görmez, Kadir Coşkun, Hatice Doğan, Yasemin Yulaf, Hasan Turan Karatepe, Arzu Çalişkan Demir, Neşe Yorguner Küpeli, Hatice Güneş, Özge Kılıç, Ahmet Gül, Sevinc Ulusoy, Ali Evren Tufan, Sümer Öztanrıöver, Mesut Yildiz, Didem Öztop, Bengi Semerci, Vahdet Gormez, Filiz Şükrü Gürbüz, Gülşen Teksin Ünal, Ömer Faruk Akça, M. Kayhan Bahalı, Dilek Sarıkaya Varlık, Oğuz Tan, Sarper Taşkıran, Şükrü Kartalcı, Sevgi Özmen, Esra Demirci, Özgür Çağla Cenker, Mehmet Fatih Ceylan, Cagdas Oyku Memis, Selim Polat, Selma Tural Hesapçıoğlu, A Cenk Ercan, Cenk Varlik, Hatice Aksu, Bilge Doğan, Tuba Mutluer, Mustafa Solmaz, Can Tuncer, Veysi Çeri, Tuğba Uyar, Serkut Bulut, Murat Kuloğlu, İpek Güngör, and Rayna Mandova
- Subjects
Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Published
- 2017
- Full Text
- View/download PDF
15. 9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology
- Author
-
Özge Şahmelikoğlu Onur, Merve Çukurova, Sevda Bağ, Suat Yalçın, Cansu Çakır Şen, Çağatay Karşıdağ, Serdar Süleyman Can, Emine Tuğçe Akçaer, Ayşegül Taşdelen Kul, Mustafa İspir, Osman Bakkal, Ayhan Algül, Servet Ebrinç, Cihad Yükselir, Serkan Zincir, Pelin Öztürk, Bülent Karaahmetoğlu, Özlem Baş, Sema Ulukaya, Çağlar Soykan, Ali Çayköylü, Neslihan Yazar, Zehra Başar Kocagöz, Adnan Özçetin, Safiye Bahar Ölmez, Ahmet Ataoğlu, Yasin Hasan Balcioglu, Tonguc Demir Berkol, Filiz Ekim Cevik, Fatih Oncu, Guliz Ozgen, Dudu Demiröz, Hatice Yardım Özayhan, Hilal Seven, Mustafa Çağrı Yıldız, Recep Başaran, İbrahim Eren, Elif Özlem Canazlar, Levent Sevinçok, Bilge Doğan, Çağdaş Öykü Memiş, Ali Baran Tanrikulu, İkbal İnanli̇, Mustafa Çağri̇ Yi̇ldi̇z, Tuba Şerife Elmas, Ibrahim Eren, Şükrü Alperen Korkmaz, Cansu Pınar Şen, Mehmet Fatih Ceylan, Selma Tural Hesapçıoğlu, Burcu Bakar, Can Tuncer, Rümeysa Yeni Elbay, Aynur Görmez, Yusuf Tokgöz, Abdullah Bolu, Cemil Çelik, Özcan Uzun, Simge Seren Kirlioglu, Pinar Cetinay Aydin, Mustafa Uğurlu, Görkem Karakaş Uğurlu, Zuhal Koç, Nazlı Kapubağlı, Ömer Faruk Tuncer, Gülsen Ünlü, Esra Kabadayı Şahin, Zuhal Koç Apaydın, Semra Ulusoy Kaymak, Oğuz Peker, Bedriye Özkan, Ali Güven Kılıçoğlu, Gül Karaçetin, Zeynep Yücehan, Tuğba Şerife Elmas, Nafiye Yağlı, Bilge Çetin İlhan, Derya Adali Aker, Yiğit Kıvılcım, Mustafa Solmaz, Yeşim Ruhat Kutlu, Bahar Yeşil, Behice Han Almış, Başak Küçük, Cem Cerit, Burcu Sarici, Ayşe Ceren Kaypak, Erensu Baysak, Serhat Ergün, Mesut Yildiz, Aslihan Okan Ibiloglu, Abdullah Atli, Mehmet Asoglu, Mustafa Ozkan, Nursu Çakın Memik, Hatice Ünver, Özlem Yıldız Gündoğdu, Necati Uzun, Ömer Faruk Akça, Gizem Aral, Demet Sağlam Aykut, Özgür Maden, İbrahim Gündoğmuş, Fulya Gok, Seda Kiraz, Arif Cipil, Meliha Zengin Eroglu, Elvan Çiftçi, Zeynep Aslan, Melike Kevser Gül, Neslihan Taştepe, Esra Demirci, Sevgi Özmen, Hicran Doğru, Elif Karayağmurlu, Ali Karayağmurlu, Muhsine Göksu, Leyla Ezgi Tügen, Ayşe Burcu Ayaz, Ayşe Arman, Deniz Altunova, Murat İlhan Atagün, Ekrem Güldaş, Güler Göl, Uğur Savcı, Ali Evren Tufan, Seda Yıldırım Özbek, Süleyman Özbek, Hilal Uygur, Başak Demirel, İ. Esra Çiçek, Hüseyin Kara, Mehmet Murat Balcı, Servet Karaca, Mehmet Murat Kuloğlu, Hasan Mervan Aytaç, Mehmet Can Ger, Aslıhan Okan İbiloğlu, Mehmet Asoğlu, Ayşe Çakır, Ahmet Tiryaki, Gülşah Güçlü Çelme, Mehmet Hamid Boztaş, Fatma Sırmatel, Mucahid Erdogan, Cengiz Dayan, Hayrunisa Dilek Atakli, Gülşen Kartalcı, Ebru Yücel, Şükrü Kartalcı, Meliha Zengin Eroğlu, Arif Çipil, Mecit Çalışkan, Emine Cengiz Çavusoglu, Yusuf Özay Özdemir, Ebru Fındıklı, Berkan Şahin, Koray Karabekiroğlu, Mustafa Kurt, Doğa Sevinçok, Merve Sertdemir, Rukiye Ay, Nevzat Yılmaz, Sevcan Karakoç Demirkaya, Hatice Aksu, Hacer Gizem Gerçek, Gülser Karakoç, Ayşe Ender Altıntoprak, Hakan Coşkunol, Ipek Percinel Yazici, Kemal Utku Yazici, Kevser Altıntaş, Fulya Gök, Ferhat Yaylacı, Handan Özek Erkuran, Murat Eyüboğlu, Diğdem Göverti, Rabia Nazik Yüksel, Alper Bülbül, Makbule Çiğdem Aydemir, Erol Göka, Ilgaz Kınalı, Münevver Yıldırım Hacıoğlu, Burcu Sarıcı, Kemal Sayar, Hatice Doğan, Ömer Akay, Heecheol Kim, Hyunjoo Lee, Abdulkadir Karagöz, Hakan Kullakçı, Yasin Duman, Yusuf Çokünlü, Memduha Aydın, Ali Baran Tanrıkulu, İbrahım Eren, Hande Ayraler Taner, Burcu Akın Sarı, Çiğdem Yektaş, Nuran Demir Samurcu, Saliha Çalışır, Özalp Ekinci, Muhammet Emin Tan, Merve Kalınlı, Murat Kıyançiçek, Meltem Küçükdağ, Hasret Karabulut Gül, Emel Uysal, Filiz Civil Arslan, Evrim Özkorumak Karagüzel, Burak Karakök, Halime Tuna Çak, Pınar Kızılay Çankaya, İlkay Keleş Altun, Eren Abatan, Ali Metehan Çalışkan, Hatice Kübra Çakı, Burak Doğangün, Muhammed Tayyib Kadak, Mehmet Kefeli, Asiye Arıcı, Hatice Altun, Can Acıpayam, Pelin Çon Bayhan, Elif Nurgül Sungur, Ayşe Nur İnci Kenar, Sevde Afife Ersoy, Mehmet Gürkan Gürok, Sevler Yildiz, Tuba Korucu, Denizhan Danaci Keles, Murad Atmaca, Esra Hoşoğlu, Kübra Kılınç, Barış Şen, Erdem Örnek, Cengiz Çelebi, Ayşe Sakallı Kani, Ömer Yanartaş, Zeynep Şenkal, Yıldız Akvardar, Kaan Kora, Ümran Egilmez, Ali Kandeğer, Özkan Güler, Selcen Dogru Kösker, Elif Ates Budak, Zeliha Deveci Karasin, Mehmet Diyaddin Güleken, Mustafa Celik, Hande Yıldırım, Burçin Güler, Baybars Veznedaroğlu, Funda Lale, Halime Tuna Çak Esen, Göknur Haliloğlu, Nuran Ekinci, Gamze Özçürümez Bilgili, Volkan Seneger, Ümit Işık, Gonca Aşut, Elif Tatlıdil Yaylacı, Ömer Asan, Serkan Güneş, Ebru Çiftçi, Sehure Azra Yaşar, İkbal İnanlı, Sencan Sertçelik, Selma Hilal Avci, Alişan Burak Yaşar, Hasan Turan Karatepe, Melike Dönmez, Volkan Topçuoğlu, Ayhan Bilgiç, Volkan Doğru, Abdullah Bozkurt, Tuğba Kalyoncu, Deniz Argüz Çıldır, Can Beşer, Neşe Perdahlı Fiş, Şermin Bilgen Ulgar, Hamza Ayaydın, Hatice Takatak, Hamza Ayaydin, Cansu Çobanoğlu, Mahmut Müjdeci, Yusuf Yasin Gümüş, Betül Akbaş, Feyza Hatice Sevgen, Fatih Öncü, Nilfer Şahin, Damla Balkan, Fatma Coşkun, Savaş Yılmaz, Çağla Çelikkol, Ganime Dilek Emlik, Hüseyin Çaksen, Derya Arslan, Özden Arısoy, Ahmet Şair, Yaşan Bilge Şair, Dilek Sarı, Mustafa Ispir, Ayhan Algul, Vuslat Kara Ölmeztoprak, Esra Porgalı Zayman, Süheyla Ünal, Ali Hakan Öztürk, Başak Karabucak, Ebru Sadriye Çengel Kültür, Tuna Halime Çak Esen, İpek Fatma Özaktaç, Murat Altın, Ayşe Sena Sarıdoğan, Eser Buluş, Sevilay Güneş, Zehra Koyuncu, Rahime Hülya Bingöl, Mine Uzgel, Selahattin Ayas, Yüksel Kıvrak, Yiğit Şahbal, Kübra Kocagöz, Gamze Kutlu, Ali Baz, Mehmet Akif Cansız, Tugba Kalyoncu, Ebru Sağlam, Özlem Önen, Ayşe Kutlu, Ecenur Aydın Aşık, Şermin Yalın Sapmaz, Serpil Erermiş, Şahika Gülen Şişmanlar, İsmail Karka, Fethiye Kilicaslan, Ceren Enüstün Hürmeydan, Ozge Sahmelikoğlu Onur, Didem Nagehan Sarı, Bahar Kılıç, Elif Merve Kurt, İsmail Ak, Ali Emre Şevik, Ayşe Dilara Yalçın, Ümit Tural, Hilmi Yaşar, Münir Karaaslan, Fatih Kizilağaç, Taner Öznur, Ali̇ Baran Tanri̇kulu, Mustafa Çağri Yildiz, İkbal İnanli, Seher Serez Öztürk, Seda Özbek, İsmet Esra Çiçek, Rıfat Karlıdağ, Mustafa Akan, Lara Utku İnce, İsmail Reyhani, Dilek Çağlar Tetik, Ayşe Büyükaslan, Musa Yılanlı, Ender Cesur, Fatma Belger, Bürge Kabukçu Başay, Cansu Pinar Şen, Selma Tural Hesapcioglu, Gülşen Teksin, Nese Yorguner Kupeli, Serhat Ergun, Abdullah Atlı, Öznur Akıl, and Aslıhan Okan İbilioğlu
- Subjects
Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Published
- 2017
- Full Text
- View/download PDF
16. 9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology
- Author
-
Abdurrahim Bakirhan, Safak Yalcin Sahiner, Volkan Sahiner, Şahabettin Çeti̇n, Melike Ceyhan Balcı Şengül, Sema Kuş, Fatih Canan, Ali Erdoğan, Mehmet Murat Kuloğlu, Şengül Şahin, Gülçin Elboğa, Ahmet Zi̇ya Şahin, Ahmet Ünal, Abdurrahman Altındağ, Osman Hasan Tahsin Kılıç, Turkan Dogan, Gonul Kaygisiz, Zeynep Ezgi Bal, Mustafa Solmaz, Derya Adali Aker, Ercan Akin, Samet Kose, Deniz Deniz Özturan, Hatice Özyıldız Güz, Muhammet Emin Naldan, Ali Karayağmurlu, Mehmet Nuri Cevizci, Duygu Kara, Elif Oral Ahiskalioğlu, Pelin Aydın, Yıldız Marangoz, Burcu Akın Sarı, Zeren Barış, Figen Özçay, Başak Tüzün Mutluer, Tuna Güzide Yener Orum, Ebru Şahan, Sencan Sertcelik, Helin Yılmaz, N. Burcu Özbaran, Melis Palamar, Elif Demirkılıç Biler, Ertan Yi̇lmaz, Lut Tamam, Murat Altın, Ipek Fatma Ozaktac, Ayse Sena Sarıdogan, Figen Yavlal, Ceyda Tahincioğlu, Hakan Karaş, Hüseyin Ebadi, Suna Sogucak, Servet Karaca, Murat Kuloglu, Taner Öznur, Abdullah Bolu, Havva Öznur, Serdar Atik, Cemil Çelik, Özcan Uzun, Erol Göka, Tijen Utkan, Tuğçe Demirtaş Şahin, Yusufhan Yazir, Zehra Seda Halbutoğulları, Semil Selcen Gocmez, Feyza Arıcıoğlu, Övgü Sinem Buğan Gülbahar, Abda Mahmood, Enikő Zsoldos, Charlotte L. Allan, Anya Topiwala, Klaus P. Ebmeier, Jung Suk Lee, Jong Hun Kim, Seon-Koo Lee, Gökhan Ünal, Alim Hüseyin Dokumacı, Mükerrem Betül Aycan Yerer, Ceren Özkartal, Hülya Kamarlı Altun, İlkay Keser, Mehmet Mart, Didem Tezcan, Selim Tümkaya, Figen Çulha Ateşci, Cansu Baygın, Çağdaş Öykü Memiş, Bilge Doğan, Levent Sevinçok, Gonca Karakuş, Ceren Şahin Özkartal, Erdem Tüzün, Rümeysa Keleş, Cansu Kandemir, Serap Şirvancı, Cem İsmail Küçükali, Özgür Devrim Can, Umut İrfan Üçel, Ümide Demir Özkay, Emel Ulupınar, Nazlı Turan, Nafiz Öncü Can, Tuğçe Baştaşkın, Canan Yalçınkaya, Gülnaz Arkan, Yusuf Özkay, Serkan Levent, Feyza Alyu, Yusuf Öztürk, Bassem Sadek, Nadia Khan, Dorota Łażewska, Katarzyna Kieć Kononowicz, Mehmet Hamid Boztaş, Derya Arslan, Ayşegül Koç, Derya Öktem Aygün, Hülya Ensari, Ercan Akın, Vedat Ceylan, Mehmet Hakan Turkcapar, Mehmet Yalcin, Hakan Turkcapar, Feryal Cam Celikel, Güzin M Sevinçer, Aysenur Kaya, Suleyman Bozkurt, Nilufer Subasi Tekintas, Fatma Benk Durmus, Kemal Sayar, Fatma Kartal Sarıoğlu, Lale Gönenir Erbay, Rıfat Karlıdağ, Ebru Sekmen, Zeynep Selen Karalök, Zeynep Göker, Esra Çöp, Gülser Dinç, Özlem Hekim Bozkurt, Özden Şükran Üneri, Safinaz Ataoğlu, Handan Ankaralı, Seyit Ankaralı, Büşra Bahar Ataoğlu, Safiye Bahar Ölmez, Esra Çelebi, Özge Pasin, Rumeysa Samancı, Didem Ayyıldız, Neşe Perdahlı Fiş, Hatice Yardi̇m Özayhan, Ali Metehan Çalışkan, İkbal İnanlı, Halil İbrahim Öztürk, Tahsin Etli, İbrahim Eren, Hande Ayraler Taner, Fethiye Kilicaslan, Hamza Ayaydin, Ayca Idil Aytekin, Melek Saka, Sule Aydin, Beyazit Garip, Hakan Kayir, Görkem Karakaş Uğurlu, Mustafa Uğurlu, Ayza Mutlu Haydanlı, Ali Çayköylü, Semra Ulusoy Kaymak, Zuhal Koç Apaydın, Serdar Süleyman Can, Abdullah Bozkurt, Seher Akbaş, Burak Tander, Cengiz Kara, Ünal Bıçakçı, Hamiyet İpek Toz, Özhan Yalçi̇n, Şermin Yalın Sapmaz, Handan Özek Erkuran, Dilay Karaarslan, Masum Öztürk, Gülsüm Yörük Ülker, Burcu Serim Demirgören, Ertuğrul Köroğlu, Ömer Aydemir, Nefize Yalın, Canem Kavurma, Siğnem Öztekin, Birsen Şentürk Pilan, Neslihan Inal Emiroğlu, Dilek Ergin, Nesrin Şen Celasin, Öznur Bilaç, Duygu Kararslan, Mahmut Cem Tarakçıoğlu, Gülşah Acar, Kerime Bademli, Neslihan Lök, Ahmet Zihni Soyata, Mahmut Onur Karaytug, Necla Keskin, Nurgul Ozpoyraz, and Mehmet Emin Demirkol
- Subjects
Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Published
- 2017
- Full Text
- View/download PDF
17. Reversible cycloplegia caused by duloxetine: a case report
- Author
-
Rabia Nazik Yüksel, Vahap Ozan Kotan, and Erol Göka
- Subjects
Duloxetine ,cycloplegia ,side effects ,adverse effects ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
A Duloxetine is a balanced and potent dual reuptake inhibitor of serotonin and norepinephrine (SNRI) that has previously been shown to be effective in the treatment of major depressive disorder (MDD), generalized anxiety disorder, and diabetic peripheral neuropathic pain (DPNP). Cycloplegia is paralysis of the ciliary muscle of the eye, resulting in a loss of accommodation. Here, we present a reversible cycloplegia case caused by duloxetine use. The patient was a 24 years-old woman with MDD diagnosis. Patient had somatic symptoms like fatigue, myalgia, and headache, besides her depressive symptoms for the last two months. Escitalopram and sertraline were used for her MDD before and she had to quit both owing to side effects such as nausea and drowsiness. Duloxetine 30mg/day treatment was started in our outpatient clinic. In her first follow-up exam, she reported light sensitivity and increased visual impairment. The visual impairment led dizziness and an increase in headache. She was consulted to ophthalmology unit of our hospital and cycloplegia was detected in her eye examination. Duloxetine was stopped in the ninth day of treatment but cycloplegia negatively affected the patient's daily life for almost 4 weeks and impaired her functionality. Because of the paralysis of the ciliary muscle, the curvature of the lens can no longer be adjusted to focus on nearby objects. Eye pain, changes in vision and swelling or redness in or around the eye are mentioned as possible visual side effects in the medication of duloxetine. The ocular and visual side effects from a patient's systemic medication can range from mild to severe. These side effects may or may not be serious enough to warrant discontinuing treatment. Cycloplegia seems as a rare adverse effect in antidepressant treatment and may take a long time to wash out. Recognition of ocular and visual side effects is important to prevent and minimize serious complications. In such visual disturbances, eye examination of the patient should be performed and the responsible drug should be discontinued as early as possible.
- Published
- 2017
- Full Text
- View/download PDF
18. Association of Glial Cell-Line Derived Neurotrophic Factor and Nerve Growth Factor with Duration of Untreated Psychosis and Clinical Symptoms in Drug-Naive Schizophrenia
- Author
-
Erol Göka, Safak Yalcin Sahiner, Ömer Asan, Andac Uzdogan, and Baise Tıkır
- Subjects
medicine.medical_specialty ,biology ,business.industry ,Neurosciences. Biological psychiatry. Neuropsychiatry ,medicine.disease ,Untreated psychosis ,Drug-naïve ,Endocrinology ,Nerve growth factor ,Schizophrenia ,Internal medicine ,Glial cell line-derived neurotrophic factor ,biology.protein ,medicine ,Association (psychology) ,business ,medicine.drug ,RC321-571 - Published
- 2021
19. Low Anti-Mullerian Hormone Levels Are Associated with the Severity of Anxiety Experienced by Healthcare Professionals During the COVID-19 Pandemic
- Author
-
Hüseyin Levent Keskin, Erol Göka, Ceylan Bal, Serap Aydın, Gülin Feykan Yeğin, Elçin İşlek Seçen, and Raziye Desdicioğlu
- Subjects
0301 basic medicine ,Adult ,Anti-Mullerian Hormone ,medicine.medical_specialty ,Beck Anxiety Inventory ,Reproductive medicine ,Down-Regulation ,Anxiety ,Nursing Staff, Hospital ,Midwifery ,Risk Assessment ,Severity of Illness Index ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Predictive Value of Tests ,Risk Factors ,Intensive care ,Linear regression ,medicine ,Humans ,Ovarian reserve ,Ovarian Reserve ,030219 obstetrics & reproductive medicine ,biology ,business.industry ,Obstetrics and Gynecology ,COVID-19 ,Internship and Residency ,Anti-Müllerian hormone ,humanities ,030104 developmental biology ,Standard error ,biology.protein ,Female ,medicine.symptom ,business ,Reproductive Endocrinology: Original Article ,Biomarkers ,Clinical psychology - Abstract
The objective of this study is to investigate a possible correlation between anxiety status and anti-Mullerian hormone (AMH) levels among healthcare professionals who provide medical care directly to COVID-19-positive patients during the recent pandemic. Fifty-two healthcare professionals (nurses, midwives, and residents) who provide medical care directly to COVID-19-positive patients in inpatient clinics or intensive care units were enrolled in this study. Serum AMH levels were analyzed to reflect ovarian reserve. The Beck Anxiety Inventory (BAI) and the State-Trait Anxiety Inventory (STAI-S and STAI-T, respectively) were completed by participants to assess their anxiety status. A linear regression model with participant age as the constant variable was applied to analyze the relationship between inventory scale scores and AMH levels. P-values less than 0.05 were considered statistically significant. The mean AMH value was significantly lower for the participants in the moderate/severe anxiety group compared to the minimal/mild anxiety group (p = 0.007). A linear regression analysis revealed a significant negative correlation between AMH levels and both BAI (B = -0.030, standard error = 0.010, p = 0.004) and STAI-S and STAI-T scores when age was controlled (both p = 0.003). The severity of anxiety experienced during the recent COVID-19 pandemic among healthcare professionals, who provide medical care directly to COVID-19-positive patients, is found to be related to low AMH levels.
- Published
- 2021
20. Thiol/Disulfide Homeostasis in Bipolar and Unipolar Depression
- Author
-
Rabia Nazik Yüksel, Gamze Erzin, Sinan Guloksuz, Güven Özkaya, Canan Topcuoglu, Emine Feyza Yurt, Erol Göka, Ozcan Erel, Psychiatrie & Neuropsychologie, and RS: MHeNs - R2 - Mental Health
- Subjects
DISORDER ,medicine.medical_specialty ,Bipolar depression ,Mood disorder ,Oxidative phosphorylation ,METABOLISM ,medicine.disease_cause ,03 medical and health sciences ,Behavioral Neuroscience ,0302 clinical medicine ,Internal medicine ,medicine ,GLUTATHIONE ,Outpatient clinic ,Pharmacology (medical) ,Bipolar disorder ,RATING-SCALE ,VALIDITY ,Depression (differential diagnoses) ,chemistry.chemical_classification ,OXIDATIVE STRESS MARKER ,business.industry ,Unipolar depression ,medicine.disease ,Pathophysiology ,LIPID-PEROXIDATION ,030227 psychiatry ,Psychiatry and Mental health ,Endocrinology ,chemistry ,Oxidative stress ,RELIABILITY ,Thiol ,Original Article ,business ,OLANZAPINE ,030217 neurology & neurosurgery ,Homeostasis ,REDOX SYSTEMS - Abstract
Objective: Bipolar disorder and unipolar depressive disorder are complex phenotypes. There appear to be phenotypical, mechanistic, and therapeutic differences between bipolar depression (BD) and unipolar depression (UD). There is a need for understanding the underlying biological variation between these clinical entities. The role of oxidative processes underlying bipolar disorder and depression has been demonstrated. Thiol-disulfide homeostasis (TDH) is a recent oxidative stress marker. In this study, we aimed to inspect patients with bipolar depression and unipolar depression in terms of thiol-disulfide balance and to compare them with healthy controls.Methods: Patients admitted to the outpatient clinic of Ankara Numune Training and Research Hospital and diagnosed either as a depressive episode with bipolar disorder (n = 37) or unipolar depression (n = 24) according to DSM-5 criteria, along with healthy controls (HC) (n = 50), were included in the study. Native thiol, total thiol, and disulfide levels were compared across the groups.Results: In comparison to HC, both BD and UD groups had higher disulfide levels, disulfide/native thiol ratio, and disulfide/total thiol ratio. No significant differences between BD and UD were detected in terms of disulfide level, disulfide/native thiol ratio, and disulfide/total thiol ratio.Conclusion: Increased levels of disulfide, native thiol, and disulfide/total thiol ratios compared to healthy controls in both UD and BD groups may be indicative of the presence of oxidative damage in these two clinical conditions. To clarify the role of oxidative stress in the pathophysiology of depressive disorders and investigate TDH, longitudinal studies in patients with medication-free UD and BD are required.
- Published
- 2020
21. Association between treatment motivation, addiction characteristics, craving and temperament traits in male patients with alcohol addiction
- Author
-
İlker Dalğar, Gamze Erzin, Erol Göka, Ahmet Kokurcan, Oğuzhan Kılınçel, Merve Cingi, and İhsan Tuncer Okay
- Subjects
alkol,aşerme,motivasyon ,media_common.quotation_subject ,Craving ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,motivation ,mental disorders ,Medicine ,030212 general & internal medicine ,Association (psychology) ,motivasyon ,General Environmental Science ,media_common ,Psychiatry ,lcsh:R5-920 ,Alcohol addiction ,alkol ,business.industry ,alcohol ,craving ,temperament traits ,Addiction ,Psikiyatri ,aşerme ,Male patient ,General Earth and Planetary Sciences ,Treatment motivation ,Temperament ,medicine.symptom ,business ,Substance abuse treatment ,lcsh:Medicine (General) ,alcohol,craving,motivation,temperament traits ,Clinical psychology - Abstract
Amaç: Bu araştırmanın amacı, yatarak tedavi gören erkek alkol bağımlılarında tedavi motivasyonu, bağımlılık özellikleri, aşerme ve mizaç özellikleri arasındaki ilişkiyi incelemektir.Gereç ve Yöntem: Ankara Numune Eğitim ve Araştırma Hastanesi, Alkol-Madde Araştırma, Tedavi ve Eğitim Merkezi’nde (AMATEM) yatarak tedavi gören DSM-IV-TR’ye göre alkol bağımlılığı tanısı almış erkek hastalar çalışmaya dahil edilmiştir. Hastalar, sosyodemografik veri formunun yanı sıra, Penn Alkol Aşerme Ölçeği (PAAÖ), Bağımlılık Profil İndeksi (BAPİ), Değişime Hazır Olma ve Tedavi İsteği Ölçeği (SOCRATES), Memphis, Pisa, Paris ve San Diego - Self Mizaç Değerlendirme Ölçeği (TEMPS-A) kullanılarak değerlendirildi.Bulgular: Çalışmaya 85 erkek hasta dahil edildi. Çalışma kapsamındaki hastaların ortalama yaşı 46.36 ± 9.66’ydı. Katılımcıların ortalama alkol kullanma süreleri ise 23.32 ± 10.33 yıldı. Çalışmanın sonuçlarına göre BAPİ toplam puanı ve PAÖÖ toplam puanı arasında pozitif korelasyon hesaplanmıştır.Sonuç: Bağımlılık şiddetinin artmasıyla aşerme şiddetinin artması bağımlılık şiddeti yüksek olan hastalarda aşerme konusunda daha dikkatli olmak gerektiğini düşündürebilir. Baskın mizaç özelliğine sahip olup olmamanın aşerme, motivasyon ve bağımlılık şiddeti ile olan ilişkisi çalışmamızda saptanmamıştır., Purpose: The aim of this study is to investigate the relationship between the treatment motivation, addiction characteristics, craving and temperament traits in male patients with alcohol addiction having inpatient treatment.Materials and Methods: Male patients diagnosed with alcohol addiction according to DSM-IV-TR having inpatient treatment at Ankara Numune Training and Research Hospital’s Alcohol and Substance Abuse Treatment and Training Center (AMATEM) were included in the study. The patients were evaluated by sociodemographic data form, Penn Alcohol Craving Scale (PACS), Addiction Profile Index (API), The Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES), Temperament Evaluation of Memphis, Pisa, Paris and San Diego Autoquestionnaire (TEMPS-A).Results: 85 male patients were included in the study. The mean age of the participants was 46.36 ± 9.66. The mean of the years of using alcohol was 23.32 ± 10.33. A positive correlation was found between API total score and PACS total score according to the study. Conclusion: Increasing craving severity aligned with increasing addiction severity may suggest that patients with high addiction severity should be given more care in terms of craving. The relationship between having a dominant temperament and craving, motivation and severity of addiction could not be determined in our study.
- Published
- 2020
22. Evaluation of Anxiety, Burnout and Psychological Resilience Levels of Healthcare Workers in the COVID-19 Pandemic
- Author
-
Rabia Nazik Yüksel, Nihan Büyüklüoğlu, Hasan Kaya, Erol Göka, Aybeniz Civan Kahve, and Saniye Gökçe Saykal
- Subjects
Psychiatry ,Coronavirus disease 2019 (COVID-19) ,business.industry ,General Medicine ,Burnout ,COVID-19,mental health,healthcare workers,burnout,resilience ,Psikiyatri ,Pandemic ,Health care ,medicine ,Anxiety ,medicine.symptom ,business ,Psychology ,Clinical psychology - Abstract
Purpose: The COVID-19 pandemic affects mental health as well as physical health. Many studies have shown that the pandemic has negative effects on the mental health of individuals. Determining the factors that play a role in the psychological resilience and burnout levels of healthcare workers, who are at the forefront of the pandemic, will play an important role in preventive and therapeutic planning in pandemic management. Our aim is to evaluate the anxiety-burnout levels and psychological resilience levels in healthcare workers and the factors affecting them. Method:Sociodemographic data form, State-Trait Anxiety Scale (STAI), Connor-Davidson Psychological Resilience Scale (CD-RISC) and Maslach Burnout Inventory, were created in Google Documents and applied to the Healthcare workers via mail and message groups and social media groups. A total of 257 people were included in the study.Results: In our study, high trait anxiety scores and increased working were associated with increased levels of burnout. Doctors and nurses showed more signs of burnout than auxiliary assistant staff. The emotional exhaustion and personal accomplishment were higher in females. Psychological resilience could predict personal accomplishment sub-dimension and total scores of MBI.Conclusions: Healthcare workers are at risk for burnout. Working conditions should be regulated and psychosocial support programs should be established for healthcare workers who are at the forefront in pandemic.
- Published
- 2021
23. Do Anxiety and Depression Levels Affect the Inflammation Response in Patients Hospitalized for COVID-19
- Author
-
Merve Okuyucu, Sureyya Barun, Aybeniz Civan Kahve, Yunus Hacimusalar, Hasan Kaya, and Erol Göka
- Subjects
medicine.medical_specialty ,Beck Anxiety Inventory ,Psychological intervention ,Inflammation ,Disease ,Anxiety ,Procalcitonin ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Medicine ,030212 general & internal medicine ,Plasma biomarkers ,Biological Psychiatry ,Depression (differential diagnoses) ,business.industry ,Depression ,Beck Depression Inventory ,COVID-19 ,Psychiatry and Mental health ,Original Article ,medicine.symptom ,business ,030217 neurology & neurosurgery - Abstract
Objective The whole world is still struggling with the COVID-19 pandemic. Inflammation response, thought to be associated with severe illness and death, is an important research topic in COVID-19. Inflammation is also an essential condition explored in psychiatric illnesses. Our knowledge about the relationship between the inflammation response and psychiatric comorbidities in patients with COVID-19 is very limited. In this study, the relationship between anxiety and depression levels and inflammation response of patients with COVID-19 hospitalized in the hospital was examined.Methods 175 patients were included in the study. Sociodemographic Data Form, Beck Depression Inventory and Beck Anxiety Inventory were applied to the patients. To evaluate the inflammation responses, blood sedimentation rate, C-reactive protein (CRP), procalcitonin, ferritin, neutrophil/lymphocyte ratio (NLR), and IL-6 levels were examined.Results In our study, no relationship was found between anxiety and depression levels and inflammatory responses in patients hospitalized with a diagnosis of COVID-19. Anxiety and depression levels of women were higher than men, and NLR, ferritin, IL-6 levels were found to be lower than men. Anxiety levels increase with age. There is a positive correlation between NLR and ferritin levels and duration of hospitalization.Conclusion Our study examining the relationship of psychiatric comorbidities with the inflammation response and our increasing literature knowledge, together with studies evaluating the mental effects of COVID-19, suggest that determining the relationship between inflammation responses and psychiatric comorbidities in COVID-19, whose pathophysiology has not been clarified yet, maybe an essential step in interventions on the course of the disease.
- Published
- 2021
24. From predictions to evidence: Treatment compliance, disease progression and social compliance of patients with schizophrenia in the COVID‐19 pandemic
- Author
-
Atike Gul Cakil, Erol Göka, Hasan Kaya, Yagmur Darben, and Aybeniz Civan Kahve
- Subjects
medicine.medical_specialty ,Inclusion (disability rights) ,medicine.medical_treatment ,Compliance (psychology) ,03 medical and health sciences ,Social support ,0302 clinical medicine ,COVID‐19 ,Pandemic ,medicine ,Humans ,Medical prescription ,Psychiatry ,Antipsychotic ,treatment compliance ,Pandemics ,030504 nursing ,business.industry ,SARS-CoV-2 ,Telepsychiatry ,COVID-19 ,General Medicine ,Original Articles ,medicine.disease ,Telemedicine ,030227 psychiatry ,social compliance ,schizophrenia ,antipsychotics ,Schizophrenia ,Disease Progression ,Patient Compliance ,Original Article ,Pshychiatric Mental Health ,0305 other medical science ,business ,Antipsychotic Agents - Abstract
Purpose This study explored how patients with schizophrenia were provided with social support and treatment compliance during the pandemic. Design and Methods A total of 396 patients with schizophrenia and their relatives were interviewed by telephone calls. Findings Multiple antipsychotic use and depot antipsychotics were not superior in preventing relapse. A total of 70.2% of the patients wanted to meet with their psychiatrist online but only 7.1% of them were reached online. A total of 59% of patients were able to take their medication thanks to the extension of their drug prescriptions. Practice Implications Active inclusion of telepsychiatry applications in clinical practice is necessary for patients with schizophrenia. Government policies developed for treatment compliance seem important.
- Published
- 2021
25. The severity of dissociative symptoms among patients with cannabis and synthetic cannabinoid use disorder: association with substance use characteristics and suicide
- Author
-
Erol Göka, İhsan Tuncer Okay, Bengü Yücens, and Vahap Ozan Kotan
- Subjects
cannabis ,medicine.drug_class ,medicine.medical_treatment ,Neurosciences. Biological psychiatry. Neuropsychiatry ,Pharmacology ,dissociation ,Dissociative ,Synthetic cannabinoids ,medicine ,Pharmacology (medical) ,Substance addiction ,substance addiction ,suicide ,integumentary system ,biology ,business.industry ,biology.organism_classification ,Psychiatry and Mental health ,nervous system ,Cannabinoid ,Cannabis ,Substance use ,business ,tissues ,medicine.drug ,RC321-571 - Abstract
OBJECTIVE: Cannabis (C) and synthetic cannabinoids (SCs) are commonly used substances. Pharmacodynamic and pharmacokinetic differences predict that SCs involve a greater risk of dependence than C. Dissociative symptoms and suicidality are also frequent in treatment-seeking substance users, however, there is not enough data about the dissociative effects of C and SCs. The present study aimed to examine SC users in terms of demographic features and severity of dissociative symptoms in comparison to C users. It was also aimed to explore the relationships between dissociation and suicide attempts. METHODS: The study was performed at the Alcohol and Substance Research, Treatment, and Training Centre of Ankara Numune Training and Research Hospital, Turkey. 84 patients with C or SC use disorder included in the study and all the participants were administered a sociodemographic data form assessing also substance use features and suicide attempts and Dissociative Experiences Scale (DES). The patients were separated into three groups as only C users (CU), only SC users (SCU) and both C and SC users (C&SCU) and also categorized as DES score
- Published
- 2019
26. Sexual functions and prolactin levels in patients with bipolar disorder
- Author
-
Gamze Erzin, Elif Tatlıdil Yaylacı, Emine Merve Akdağ, Adem Demirci, Rabia Nazik Yüksel, Erol Göka, Hasan Kaya, and Çiğdem Aydemir
- Subjects
sexual functions ,medicine.medical_specialty ,business.industry ,lcsh:RC435-571 ,medicine.disease ,mood disorders ,Prolactin ,golombok rust inventory of sexual satisfaction ,Psychiatry and Mental health ,Endocrinology ,lcsh:Therapeutics. Psychotherapy ,lcsh:RC475-489 ,sexual dysfunction ,sexual disorders ,Internal medicine ,lcsh:Psychiatry ,medicine ,In patient ,Bipolar disorder ,Sexual function ,business - Abstract
Objective: Mood stabilizers and antipsychotic drugs are known to have adverse effects on sexual function. However, patients often refrain from speaking about sexual complaints that may cause dose reduction and discontinuation of the drug without medical supervision. In this study we aimed to evaluate sexual functions of patients with bipolar disorder in remission period, considering prolactin levels and medications. Method: We recruited 52 patients with bipolar disorder in remission according to DSM-IV diagnostic criteria. Prolactin levels were measured in all patients. The Golombok Rust Inventory of Sexual Satisfaction (GRISS) was used to assess sexual dysfunction. Results: Mean prolactin levels were 24.71 ± 4.25 and 19.96 ± 5.52 ng/ml respectively for females and males. Patients taking mood stabilizer (MS) and mood stabilizer plus antipsychotic (AP) treatment had different prolactin levels (p
- Published
- 2019
27. Serum PGE2, 15d-PGJ, PPAR gamma and CRP levels in patients with schizophrenia
- Author
-
Elif Tatlıdil Yaylacı, Gamze Erzin, Turan Turhan, Cevdet Züngün, Rabia Nazik Yüksel, Ayşe Pınar Titiz, Kübranur Ünal, Makbule Çiğdem Aydemir, and Erol Göka
- Subjects
Adult ,Male ,medicine.medical_specialty ,Prostaglandin ,Inflammation ,Disease ,Dinoprostone ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Internal medicine ,Medicine ,Humans ,Prostaglandin E2 ,Receptor ,General Psychology ,Positive and Negative Syndrome Scale ,business.industry ,Prostaglandin D2 ,General Medicine ,Middle Aged ,medicine.disease ,030227 psychiatry ,PPAR gamma ,Psychiatry and Mental health ,Endocrinology ,C-Reactive Protein ,chemistry ,Schizophrenia ,Biomarker (medicine) ,Female ,lipids (amino acids, peptides, and proteins) ,medicine.symptom ,business ,030217 neurology & neurosurgery ,Biomarkers ,medicine.drug - Abstract
Many hypotheses have been proposed for the development of schizophrenia, including the one proposing that exogenous and endogenous factors are linked to inflammatory processes. There is strong evidence about the immunological and inflammatory dysfunction in schizophrenia. In this study, we aimed to measure serum 15-deoxy-delta(12,14)-prostaglandin J (15d-PGJ), peroxisome proliferator-activated receptor gamma(PPAR gamma), prostaglandin E2 (PGE2) and C-reactive protein (CRP) levels. Forty-four patients and 39 healthy volunteers were included in the study. Serum PGE2, 15d-PGJ, PPAR gamma and CRP levels were measured in both the groups. Demographic data forms were filled out for the patient group, and the Positive and Negative Syndrome Scale, Clinical Global Impression-Severity scale and Calgary Depression scale were used to assess patients' clinical status. Serum PGE2, 15d-PGJ and PPAR gamma levels were found to be significantly lower in patients with schizophrenia than in healthy controls. There was no significant relationship between the serum PGE2, 15d-PGJ and PPAR gamma levels and CRP levels.In this study, the evidence of systemic inflammatory conditions in patients with schizophrenia was found. The duration of the disease has been found to be the only variable that independently affects all three biomarker levels in the patients with schizophrenia.
- Published
- 2019
28. Quality of life and pain perception in alcohol dependence: A comparative examination of patients, their relatives, and healthy controls
- Author
-
Irem Ekmekci Ertek, Rabia Nazik Yüksel, Erol Göka, Vahap Ozan Kotan, and Mustafa Ender Taner
- Subjects
Health (social science) ,genetic structures ,business.industry ,media_common.quotation_subject ,Addiction ,Alcohol dependence ,030508 substance abuse ,Medicine (miscellaneous) ,03 medical and health sciences ,0302 clinical medicine ,Quality of life (healthcare) ,Perception ,Pain perception ,Medicine ,Quality (business) ,030212 general & internal medicine ,0305 other medical science ,business ,psychological phenomena and processes ,media_common ,Clinical psychology - Abstract
Objective: The aim of this study was to investigate how quality of life and the perception of pain are affected by patients with alcohol dependence and their relatives compared with healthy controls. Methods: Fifty patients with alcohol dependence, 50 first-degree relatives of patients with alcohol dependence, and 50 healthy controls were included. Participants were evaluated with a questionnaire form of sociodemographic characteristics, and the World Health Organization Quality of Life-Bref-Turkish form (WHOQOL-BREF-TR). They were then given a noxious stimulus using a transcutaneous electrical nerve stimulation (TENS) device. After that, pain threshold, pain tolerance, and visual analog scale (VAS) scores of the participants were measured. Results: Patients' quality of life was poorer than the relative and control groups. The age of first alcohol use was found to be positively associated with quality of life. Pain tolerance was found to be higher in the patients than in the controls. We found no relationship between pain perception and characteristics of addiction. Conclusions: In this study, pain tolerance was found to be higher in patients with alcohol dependence, and the characteristics of addiction did not seem to affect pain perception.
- Published
- 2019
29. The relationship between internalized stigma and treatment motivation, perceived social support, depression and anxiety levels in opioid use disorder
- Author
-
Samet Kose, Baise Tıkır, Emine Merve Akdağ, Vahap Ozan Kotan, Makbule Çiğdem Aydemir, İhsan Tuncer Okay, Erol Göka, Güven Özkaya, and HKÜ, İktisadi, İdari ve Sosyal Bilimler Fakültesi, Psikoloji Bölümü
- Subjects
Beck Anxiety Inventory ,education ,Neurosciences. Biological psychiatry. Neuropsychiatry ,Substance use disorder ,Social support ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Pharmacology (medical) ,030212 general & internal medicine ,Treatment motivation ,Depression (differential diagnoses) ,Depression ,Beck Depression Inventory ,Opioid use disorder ,medicine.disease ,Mental illness ,030227 psychiatry ,Substance abuse ,Psychiatry and Mental health ,internalized stigma ,İnternalized stigma ,Anxiety ,treatment motivation ,social support ,depression ,medicine.symptom ,Psychology ,RC321-571 ,Clinical psychology - Abstract
OBJECTIVE: This study aims to examine how internalized stigma differs in opioid use disorder (OUD) based on sociodemographic and clinical variables, and to what extent internalized stigma is related to treatment motivation, perceived social support, depression, and anxiety levels. METHODS: One hundred forty-five individuals with OUD included. Sociodemographic and clinical data form, the Internalized Stigma of Mental Illness Scale (ISMI), Treatment Motivation Questionnaire (TMQ), Multidimensional Scale of Perceived Social Support, the Beck Depression Inventory, and the Beck Anxiety Inventory were utilized in the study to collect data. Bivariate and partial correlation coefficients between variables were computed. ISMI and TMQ scores were compared between patients with depressive symptoms and patients without depressive symptoms by using t-test and Mann Whitney U test. RESULTS: Internalized stigma was high among male patients with heroin use disorder. There was a positive correlation between internalized stigma score and treatment motivation, depression, and anxiety levels. On the other hand, there was a negative correlation between internalized stigma score and multidimensional perceived social support. CONCLUSION: Internalized stigma occupies an important place in the treatment of OUD, which occurs with frequent relapses and which is hard to treat. Not only application for treatment but also adherence to treatment and treatment motivation at maintenance phase bestow a complicated relationship with depression and anxiety. In the struggle against internalized stigma, it plays a vital role to mobilize people's social support systems, to educate families on the issue and to get in touch with support units exclusive to heroin users.
- Published
- 2018
30. Thiol/Disulphide Homeostasis in Men with Heroin Addiction
- Author
-
İhsan Tuncer Okay, Abdurrahim Bakirhan, Salim Neselioglu, Ozcan Erel, Serkan Kiral, Fatma Yılmaz, Erol Göka, and Vahap Ozan Kotan
- Subjects
medicine.medical_specialty ,business.industry ,Addiction ,Heroin addiction ,030226 pharmacology & pharmacy ,Heroin ,03 medical and health sciences ,Psychiatry and Mental health ,Disulfide ,0302 clinical medicine ,Endocrinology ,Oxidative stress ,Internal medicine ,mental disorders ,medicine ,Thiol ,Neurology (clinical) ,business ,Thiol disulphide homeostasis ,030217 neurology & neurosurgery - Abstract
Objective: Heroin addicts have increased oxidative stress which can disturb thiol/disulfide (SH/SS) homeostasis, causing disulfide formation. No study has determined the serum thiol amount and blood disulfide amount in heroin addicts. The aim of the study was to investigate dynamic SH/SS homeostasis in heroin addicts. Methods: Serum SH/SS statuses of 31 heroin addicts and 31 healthy controls were compared to determine the changes in SH/SS homeostasis in heroin addicts. Blood serum native thiol and total thiol (ToSH) levels were measured and the disulfide bond amount was calculated as the half value of the difference between native thiol and ToSH levels. For comparison t-test was used. Results: SH and ToSH levels were significantly lower (p
- Published
- 2017
31. Association of serum brain derived neurotropic factor with duration of drug-naive period and positive-negative symptom scores in drug naive schizophrenia
- Author
-
Ismail Volkan Sahiner, Safak Yalcin Sahiner, Abdurrahim Bakirhan, Yasir Safak, and Erol Göka
- Subjects
Male ,Etiology ,Economics ,medicine.medical_treatment ,Social Sciences ,lcsh:Medicine ,Pathology and Laboratory Medicine ,0302 clinical medicine ,Medicine and Health Sciences ,Antipsychotics ,lcsh:Science ,Multidisciplinary ,Pharmaceutics ,Drugs ,Middle Aged ,Schizophrenia ,Research Design ,Female ,medicine.drug ,Research Article ,Antipsychotic Agents ,Adult ,medicine.medical_specialty ,Adolescent ,Clinical Research Design ,Period (gene) ,Affect (psychology) ,Research and Analysis Methods ,03 medical and health sciences ,Young Adult ,Pharmacotherapy ,Drug Therapy ,Diagnostic Medicine ,Internal medicine ,Mental Health and Psychiatry ,medicine ,Humans ,Association (psychology) ,Antipsychotic ,Pharmacology ,business.industry ,Brain-Derived Neurotrophic Factor ,lcsh:R ,medicine.disease ,030227 psychiatry ,Drug-naïve ,Symptom Scales ,lcsh:Q ,business ,030217 neurology & neurosurgery ,Finance - Abstract
Introduction The aim of this study was to compare the serum brain derived neurotropic factor (BNDF) levels of patients with schizophrenia who had never received an antipsychotic treatment with those of a control group. Also, to analyze the relationship between the Positive and Negative Symptom Scale (PANSS) scores and BDNF levels of the patients during the period they were drug-naive. Materials and methods The sample of the study comprised patients who presentedto the Psychiatry Clinic and were admitted after a distinctive schizophrenia diagnosis was made in accordance with the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) diagnosis classification and who were not using and never had any antipsychotic medicine. A total of 160 participants were included in the study, 80 of whom had schizophrenia patients and 80 constituted the age- and sex-matched healthy control group. Before the start of the treatment, the serum samples to be checked for the BDNF levels were collected from the patients. Results The difference between the average BDNF levels of the groups were statistically significant (t = -5.25; p˂.001). An analysis as to whether there was a relation between the BDNF levels and the drug-naive duration indicated no correlations. An examination of the relationship between PANSS scores and BDNF levels of the patients yielded no correlations. Discussion Serum BDNF levels seem to be one of the indicators of schizophrenia and its progress; nevertheless, we still do not have sufficient information about this neurotropic factor. In light of our study, the neurodevelopmental changes that occur at disease onset of the illness prominently affect the progress of the illness, which highlights the importance of the treatment in the early stages.
- Published
- 2017
32. Increased serum dehydroepiandrosterone sulfate in the first episode but not in subsequent episodes in male patients with schizophrenia
- Author
-
Elmas Beyazyüz, Murat Beyazyüz, Cüneyt Ünsal, Erol Göka, and Yakup Albayrak
- Subjects
Psychosis ,medicine.medical_specialty ,endocrine system ,Neuropsychiatric Disease and Treatment ,Neuroactive steroid ,Dehydroepiandrosterone ,Adrenocorticotropic hormone ,Cortisol ,Severity ,chemistry.chemical_compound ,Dehydroepiandrosterone sulfate ,Internal medicine ,medicine ,Mechanisms ,polycyclic compounds ,Posttraumatic-Stress-Disorder ,psychosis ,Cytokine ,Biological Psychiatry ,Testosterone ,Original Research ,First episode ,business.industry ,effect ,medicine.disease ,Neuroactive Steroids ,Psychiatry and Mental health ,Endocrinology ,chemistry ,Schizophrenia ,Level ,Androgens ,neurosteroid ,Dhea ,business ,Negative Symptoms ,hormones, hormone substitutes, and hormone antagonists - Abstract
Murat Beyazyüz,1 Yakup Albayrak,2 Elmas Beyazyüz,3 Cüneyt Ünsal,2 Erol Göka31Department of Psychiatry, Gölbasi Hasvak State Hospital, Ankara, 2Department of Psychiatry, School of Medicine, Namik Kemal University, TekirdaÄ, 3Department of Psychiatry, Ankara Numune Education and Research Hospital, Ankara, TurkeyBackground: Many studies have investigated the relationship between blood levels of dehydroepiandrosterone (DHEA) and its sulfate ester (DHEA-S), cortisol, progesterone, and testosterone and the onset, prognosis, symptom severity, and treatment response of schizophrenia. In the present study, we assessed potential differences in blood levels of neurosteroids between drug-naïve first-episode patients with schizophrenia (FES), and drug-free patients with schizophrenia who were not in the first episode but were in a phase of acute exacerbation (DFP).Materials and methods: The present study included 32 male FES, 28 male DFP, and 24 male healthy controls (HC). Groups were compared in terms of blood levels of adrenocorticotropic hormone (ACTH), cortisol, testosterone, progesterone, and DHEA-S.Results: Blood levels of ACTH, cortisol, testosterone, and progesterone were similar among the groups. The mean value of serum DHEA-S was significantly different among the groups (P
- Published
- 2014
33. Factors Associated with Depression in Patients with Schizophrenia
- Author
-
Gözde Basefe Oter, Erol Göka, Gülcan Balcı, Hatice Alkan Akdağ, Alper Bekki, Cebrail Kisa, and Anadolu Üniversitesi, Fen Fakültesi, İstatistik Bölümü
- Subjects
050103 clinical psychology ,Psychosis ,medicine.medical_specialty ,Alogia ,behavioral disciplines and activities ,03 medical and health sciences ,0302 clinical medicine ,Extrapyramidal symptoms ,mental disorders ,Medicine ,0501 psychology and cognitive sciences ,Apathy ,Family history ,Psychiatry ,Depression (differential diagnoses) ,business.industry ,Depression ,05 social sciences ,medicine.disease ,Depressive Symptoms ,030227 psychiatry ,Schizophrenia ,medicine.symptom ,business ,Diagnosis of schizophrenia - Abstract
WOS: 000387949200002, Objective: In this study, it is aimed to determine the prevalence of depression rate, socio-demographic factors related to depression and to determine the relationship between depression in schizophrenia with positive and negative symptoms, insight and antipsychotics drugs' side effects in patients with a diagnosis of schizophrenia according to the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Method: Randomly selected 120 schizophrenia patients are examined regarding socio-demographic characteristics, obtained positive and negative symptoms, depression in schizophrenia, extrapyramidal symptoms, and insight scale scores. Results: Depression rate in schizophrenia is found as 42.5%. Depression is related to low socioeconomic status, family history of psychosis and affective disorders, patients' suicide history and run-in period. Also, hallucinations and delusions sub-scales, flattening, alogia, apathy and attention sub-scales, Parkinsonism sub-scale and insight levels are found directly related to depression. Conclusions: Examining related sociodemographic factors can aid in determining depression and depression may accompany all the phases of schizophrenia. Therefore, it can be one of the basic indications of schizophrenia.
- Published
- 2016
34. Thought action fusion in Obsessive Compulsive Disorder Further examination in a Turkish clinical sample
- Author
-
KARANCI, AYŞE NURAY, BAŞTUĞ, GÜLBAHAR, CEBRAIL, KISA, ŞERİFE, CEBECİ, EROL, GÖKA, and YORULMAZ, ORÇUN
- Published
- 2006
35. Urinary retention associated with catatonia: Case report
- Author
-
Omer Asan and Erol Goka
- Subjects
Catatonia ,Globe vesicale ,Schizophrenia ,Urinary Retention ,Psychiatry ,RC435-571 ,Therapeutics. Psychotherapy ,RC475-489 - Abstract
Catatonia was first introduced by Karl Kahlbaum at 1874. Catatonia is a syndrome that includes catalepsy, waxy flexibility, stupor, negativism, mutism, and echolalia. At first, it was linked with just schizophrenia for many years but it is currently known that this disorder may occur with other medical conditions and psychiatric disorders especially mood disorders. Several complications especially pulmonary, genitourinary, gastrointestinal may occur with catatonia. Here, we aimed to report a case of urinary retention associated with catatonia and treated with ECT and benzodiazepine. As a result, urinary retention and globe vesicale should be considered in patients presented with catatonia and it should be treated urgently.
- Published
- 2019
- Full Text
- View/download PDF
36. Sexual functions and prolactin levels in patients with bipolar disorder
- Author
-
Rabia Nazik Yuksel, Elif Tatlidil Yaylaci, Hasan Kaya, Gamze Erzin, Emine Merve Akdag, Adem Demirci, Cigdem Aydemir, and Erol Goka
- Subjects
Bipolar disorder ,mood disorders ,sexual dysfunction ,sexual disorders ,sexual functions ,golombok rust inventory of sexual satisfaction ,Psychiatry ,RC435-571 ,Therapeutics. Psychotherapy ,RC475-489 - Abstract
Objective: Mood stabilizers and antipsychotic drugs are known to have adverse effects on sexual function. However, patients often refrain from speaking about sexual complaints that may cause dose reduction and discontinuation of the drug without medical supervision. In this study we aimed to evaluate sexual functions of patients with bipolar disorder in remission period, considering prolactin levels and medications. Method: We recruited 52 patients with bipolar disorder in remission according to DSM-IV diagnostic criteria. Prolactin levels were measured in all patients. The Golombok Rust Inventory of Sexual Satisfaction (GRISS) was used to assess sexual dysfunction. Results: Mean prolactin levels were 24.71 ± 4.25 and 19.96 ± 5.52 ng/ml respectively for females and males. Patients taking mood stabilizer (MS) and mood stabilizer plus antipsychotic (AP) treatment had different prolactin levels (p
- Published
- 2019
- Full Text
- View/download PDF
37. Association of serum brain derived neurotropic factor with duration of drug-naive period and positive-negative symptom scores in drug naive schizophrenia.
- Author
-
Abdurrahim Bakirhan, Safak Yalcin Sahiner, Ismail Volkan Sahiner, Yasir Safak, and Erol Goka
- Subjects
Medicine ,Science - Abstract
The aim of this study was to compare the serum brain derived neurotropic factor (BNDF) levels of patients with schizophrenia who had never received an antipsychotic treatment with those of a control group. Also, to analyze the relationship between the Positive and Negative Symptom Scale (PANSS) scores and BDNF levels of the patients during the period they were drug-naive.The sample of the study comprised patients who presentedto the Psychiatry Clinic and were admitted after a distinctive schizophrenia diagnosis was made in accordance with the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) diagnosis classification and who were not using and never had any antipsychotic medicine. A total of 160 participants were included in the study, 80 of whom had schizophrenia patients and 80 constituted the age- and sex-matched healthy control group. Before the start of the treatment, the serum samples to be checked for the BDNF levels were collected from the patients.The difference between the average BDNF levels of the groups were statistically significant (t = -5.25; p˂.001). An analysis as to whether there was a relation between the BDNF levels and the drug-naïve duration indicated no correlations. An examination of the relationship between PANSS scores and BDNF levels of the patients yielded no correlations.Serum BDNF levels seem to be one of the indicators of schizophrenia and its progress; nevertheless, we still do not have sufficient information about this neurotropic factor. In light of our study, the neurodevelopmental changes that occur at disease onset of the illness prominently affect the progress of the illness, which highlights the importance of the treatment in the early stages.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.